Big Market Research, Cerebral Infarction Brain Infarction Market Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2014’, provides an overview of the Cerebral Infarction (Brain Infarction)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cerebral Infarction (Brain Infarction), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
I have the following potential conflicts of interest to report: ... GSK, Sanofi-Aventis, The Med. Comp., Merck, Lilly, Iroko, Pfizer, Boehringer Ingelheim ...
... of Primary Angioplasty compared to Thrombolytics for Acute Myocardial Infarction ... cost-effectiveness of primary angioplasty for acute myocardial infarction. ...